Elixinol , hemp-derived CBD brand and industry veteran, announced today the launch of two new innovative CBD products focused on supporting sleep*. Elixinol's Sleep Rapid Rest Liposome and Sleep Gummies are unique, melatonin-free options for consumers to support optimal sleep. Both products include CBN, marking a first for the... Read More

Elixinol Wellness Limited ( Elixinol or the Company ) (ASX:EXL; OTCQB:ELLXF ) is pleased to communicate that Assembly Bill 45 (AB45) was signed into law by Californian Governor, Mr Gavin Newsom on 6 October 2021 , establishing a comprehensive regulatory framework for the manufacture and retail sale of products in California containing hemp derived cannabidiol (CBD), including dietary supplements, topicals, over-the-counter,... Read More

Elixinol , a global hemp-derived CBD brand and industry veteran, introduced its first line of pet products. The new collection is specifically formulated for dogs and includes a bacon-flavored tincture and two functionally focused CBD dog chews targeting specific benefits. The collection is available now on Elixinol.com. "Our... Read More

Elixinol Wellness Limited ( Elixinol Wellness or the Company ) (ASX:EXL; OTCQB:ELLXF ), a global leader in the hemp derived CBD industry, innovating, and selling hemp derived CBD products, is pleased to announce the appointment of Rob Hasselman as President Americas and Beata Silber as Global Head of R&D and Innovation. The appointments are designed to drive the Company's transformation to being a global wellness business... Read More

Elixinol , a global hemp-derived CBD brand and industry veteran, has introduced Immune Gut Health, the first and only CBD capsules powered by Ginfort ™ . A proprietary ingredient, Ginfort ™ is clinically tested to aid in digestion and contains 13 times more ginger actives than traditional ginger powders. For consumers who are focused on supporting a healthy immune system, Immune Gut Health is the latest addition to... Read More

Highlights: The UK Food Standards Agency (FSA) announced on 21 February 2020 that it had set a deadline of 31 March 2021 for CBD businesses such as Elixinol to submit valid novel food applications to permit sale of CBD products in the UK As part of the European Industrial Hemp Association's (EIHA) Novel Food Consortium, Elixinol's products are now supported by a valid novel food application EIHA has advised that both... Read More

Acquisition positions Elixinol as a leading pan-European CBD business and accelerates path to profitability Management to discuss transaction and provide business update at the Cannabis Investing Forum on March 18 Elixinol Global Limited ( Elixinol or the Company ) (ASX:EXL; OTCQB:ELLXF ) is pleased to announce that it has entered into a binding agreement for its subsidiary (Elixinol B.V.) to acquire all of the issued share... Read More